retail pharmacy

Walgreens Boots Alliance (WBA) Q2 2025 Earnings: Key financials and quarterly highlights

Walgreens Boots Alliance (WBA) Q2 2025 Earnings: Key financials and quarterly highlightsWalgreens Boots Alliance (WBA) Q2 2025 Earnings: Key financials and quarterly highlights

Walgreens Boots Alliance (NASDAQ: WBA) reported its second quarter 2025 earnings results today. Sales increased 4.1% year-over-year to $38.6 billion.…

Walgreens Boots Alliance set to report Q2 earnings. Here’s what to expect

Walgreens Boots Alliance set to report Q2 earnings. Here’s what to expectWalgreens Boots Alliance set to report Q2 earnings. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in health and wellness services, is preparing to report second-quarter results,…

WBA Earnings: Walgreens Boots Alliance reports higher Q1 sales; results beat

WBA Earnings: Walgreens Boots Alliance reports higher Q1 sales; results beatWBA Earnings: Walgreens Boots Alliance reports higher Q1 sales; results beat

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Friday reported an increase in net sales for the first quarter of 2025.…

Earnings Preview: UnitedHealth looks poised to end FY24 on a positive note

Earnings Preview: UnitedHealth looks poised to end FY24 on a positive noteEarnings Preview: UnitedHealth looks poised to end FY24 on a positive note

UnitedHealth Group (NYSE: UNH), a leading provider of health insurance and healthcare services, is expected to report fourth-quarter earnings next…

Walgreens Boots Alliance expected to report mixed Q1 2025 results

Walgreens Boots Alliance expected to report mixed Q1 2025 resultsWalgreens Boots Alliance expected to report mixed Q1 2025 results

For Walgreens Boots Alliance, Inc. (NASDAQ: WBA), 2024 was a challenging year as it lost market share to competitors and…

CVS Earnings: CVS Health Q3 adj. profit drops despite 6% revenue growth

CVS Earnings: CVS Health Q3 adj. profit drops despite 6% revenue growthCVS Earnings: CVS Health Q3 adj. profit drops despite 6% revenue growth

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced third-quarter 2024 results, reporting a decrease in adjusted earnings and…

What to look for when CVS Health (CVS) reports Q3 earnings

What to look for when CVS Health (CVS) reports Q3 earningsWhat to look for when CVS Health (CVS) reports Q3 earnings

Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a…

Infographic: How Walgreens Boots Alliance (WBA) performed in Q4 2024

Infographic: How Walgreens Boots Alliance (WBA) performed in Q4 2024Infographic: How Walgreens Boots Alliance (WBA) performed in Q4 2024

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported fourth quarter 2024 earnings results today. Sales increased 6% year-over-year to $37.5 billion.…

Walgreens Boots Alliance’s Q4 results likely to reflect market challenges

Walgreens Boots Alliance’s Q4 results likely to reflect market challengesWalgreens Boots Alliance’s Q4 results likely to reflect market challenges

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been struggling to maintain sales momentum and profitability for quite some time due…

TRxADE Health changes its name to Scienture Holdings

TRxADE Health changes its name to Scienture HoldingsTRxADE Health changes its name to Scienture Holdings

Trxade Health, Inc. (NASDAQ: MEDS), a leading health services IT company, and its wholly owned subsidiary Scienture, LLC revealed that…

Trxade Health (MEDS) Q2 2024 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) is a drug procurement and delivery platform with a mission to revolutionize the healthcare industry…

Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2024 results

Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Wednesday reported an increase in revenues and adjusted profit for the…

MEDS Earnings: A snapshot of Trxade’s Q2 2024 results

Health services IT company Trxade Health, Inc. (NASDAQ: MEDS) announced financial results for the second quarter of 2024, reporting a…

CVS Earnings: CVS Health Q2 adj. profit drops but beats estimates

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced second-quarter 2024 results, reporting a decrease in adjusted earnings despite…

CVS Health to report Q2 2024 results on Wednesday. Here’s what to expect

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) had a modest start to fiscal 2024, with sales and profit coming under…

Trxade Health closes business combination with Scienture in $103Mln deal

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, has announced the closing of its business combination with…

Key highlights from Walgreens Boots Alliance’s (WBA) Q3 2024 earnings results

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported third quarter 2024 earnings results today. Sales increased 2.6% year-over-year to $36.4 billion.…

WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable…

WBA Earnings: Walgreens Boots Alliance Q2 profit and sales beat estimates

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the second quarter of 2024. Net…

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on…

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform, focused on digitalizing the retail pharmacy…